Aging-from molecules to populations.
The mean age of the human population is steadily increasing in many areas around the globe, a phenomenon with large social, political, economic and biological/medical implications. Inevitably, this phenomenon is stimulating great interest in understanding and potentially modulating the process of human aging. To foster interactions and collaboration between diverse scientists interested in the biochemical, physiological, epidemiological and psychosocial aspects of aging, The University of Copenhagen Faculty of Health Sciences recently organized and co-sponsored a workshop entitled Aging-From Molecules to Populations. The following questions about human aging were discussed at the workshop: What is the limit of human life expectancy? What are the key indicators of human aging? What are the key drivers of human aging? Which genes have the greatest impact on human aging? How similar is aging-related cognitive decline to pathological cognitive decline associated with neurological disease? Are human progeriod diseases, characterized by premature aging, good models for "normal" human aging? Is delayed or "elite" aging informative about "normal" human aging? To what extent and by what mechanisms do early life environmental factors influence aging-associated physical and cognitive decline? To what extent and by what mechanism does the social environment influence life course outcomes? What physiological factors underlie the timing and extent of aging-associated physical and cognitive decline? How do cultural stereotypes and perceptions of aging influence the process and experience of aging? One of the primary outcomes of the workshop was a recognition that cross-disciplinary studies and "out-of-the-box" approaches, especially those that adopt an integrated life course perspective on human health status, are needed to expedite advances in aging research. This and other outcomes of the workshop are summarized and discussed in this report.
Sander
Miriam
M
Page One Editorial Services, Boulder, Colorado, USA.
Avlund
Kirsten
K
Lauritzen
Martin
M
Gottlieb
Tina
T
Halliwell
Barry
B
Stevnsner
Tinna
T
Wewer
Ulla
U
Bohr
Vilhelm A
VA
D000375:Aging; D000818:Animals; D002908:Chronic Disease / Q000628:therapy; D016207:Cytokines / Q000378:metabolism; D004249:DNA Damage; D006801:Humans; D007249:Inflammation; D008017:Life Expectancy; D008954:Models, Biological; D008957:Models, Genetic; D016296:Mutagenesis; D009422:Nervous System Diseases / Q000175:diagnosis / Q000628:therapy; D046988:Proteasome Endopeptidase Complex / Q000378:metabolism; D016615:Telomere / Q000648:ultrastructure
D016207:Cytokines; D046988:Proteasome Endopeptidase Complex
Nature. 2006 Jun 22;441(7096):1011-4
16791200
Antioxid Redox Signal. 2006 Nov-Dec;8(11-12):2007-19
17034346
J Gerontol A Biol Sci Med Sci. 2007 Jul;62(7):717-21
17634317
Am J Geriatr Psychiatry. 2008 May;16(5):343-54
18448847
J Gerontol A Biol Sci Med Sci. 2006 Oct;61(10):1082-5
17077203
Am J Epidemiol. 2007 Aug 15;166(4):367-78
17573335
Sci Aging Knowledge Environ. 2002 Mar 06;2002(9):vp2
14603030
Curr Opin Clin Nutr Metab Care. 2007 May;10(3):265-71
17414493
Paediatr Perinat Epidemiol. 2004 Sep;18(5):385-94
15367326
Biochem Soc Trans. 2007 Nov;35(Pt 5):1295-7
17956334
Psychosom Med. 2004 Jul-Aug;66(4):572-7
15272105
Genes Dev. 2007 Oct 1;21(19):2410-21
17908928
Twin Res Hum Genet. 2008 Jun;11(3):321-34
18498210
Science. 2002 May 10;296(5570):1029-31
12004104